Sung-Yun Pai
Chief, Immune Deficiency Cellular Therapy Program · DREXEL UNIVERSITY
Credentials: · ·
History
PresentImmune Deficiency Cellular Therapy Program Division · DREXEL UNIVERSITY
- Present
Immune Deficiency Cellular Therapy Program Division · Clinical Center at the National Institutes of Health
- Present
NIH Transplant and Cell Therapy Program · Clinical Center at the National Institutes of Health
- 1994–1997
Internal Medicine
- 1990–1994
Research
Transplantation outcomes for severe combined immunodeficiency, 2000-2009
New England Journal of Medicine · 2014 · First of 39 authors · 540 citations
Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States
JAMA · 2014 · 519 citations
Blood · 2013 · 444 citations
Luigi Notarangelo
70 papers
41 papers
40 papers
38 papers
36 papers
33 papers
- LG
31 papers
27 papers · 9 as a resident
Grants
- 2009–2025
Primary Immune Deficiency Treatment Consortium
National Institute of Allergy and Infectious Diseases · U54
Project lead · $80.6K · University of California, San Francisco
- 2017–2024
National Institute of Allergy and Infectious Diseases · U01
PI · $4.5M · Children's Hospital of Los Angeles
- 2016–2022
Gene Therapy for SCID-X1 with Low Dose Busulfan and a SIN-Lentiviral Vector
National Institute of Allergy and Infectious Diseases · U01
Contact PI · $4.6M · Boston Children's Hospital
- 2014–2016
Dose Finding Study of Busulfan for Newly Diagnosed Infants with SCID
National Institute of Allergy and Infectious Diseases · R34
Contact PI · $258.2K · Boston Children's Hospital
Clinical trials
- 2018–2028
Conditioning SCID Infants Diagnosed Early
Study chair · Active not recruiting · Phase 2
Center for International Blood and Marrow Transplant Research
- 2018–2028
Study chair · Recruiting · Phase 1, Phase 2
David Williams